Medison America received clearance Aug. 21 for the company's SonoAce 8800 scanner, according to M.T. Kwon, president and CEO of the Pleasanton, CA, company. A collaborative effort between Medison and development partner ATL Ultrasound of Bothell, WA, SA
Medison America received clearance Aug. 21 for the company's SonoAce 8800 scanner, according to M.T. Kwon, president and CEO of the Pleasanton, CA, company. A collaborative effort between Medison and development partner ATL Ultrasound of Bothell, WA, SA 8800 is a mid-range color Doppler scanner that carries a 64-channel digital beamformer. As an added bonus, the scanner also supports 3-D imaging and can produce qualitative 3-D images in multiple planes or volumes.
ATL will sell the unit as HDI 1500 and expects to list it between $70,000 and $100,000. Medison and ATL entered into partnership earlier this year to develop and distribute mid-range digital ultrasound scanners (SCAN 5/13/98), and HDI 1500 evolved from the cooperative efforts of the two companies.
In other Medison news, the company has received 510(k) clearance for a power Doppler mode for Combison 530D, the firm's integrated 3-D ultrasound scanner.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.